Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHET Trial: Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients
NCT06276374Recruiting
- Start
- Jul 2024
- Primary completion
- Nov 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin and clopidogrel in carotid artery disease (2 arms). Primary endpoint: Clinically significant bleeding (BARC type 2, 3, or 5) at 12 months. Started Jul 2024; status: recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
carotid artery disease
Beyond the preview
Go deeper on NCT06276374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06276374.